This review will analyze growing evidence suggesting a convergence between two major areas of research: Alzheimer's disease (AD) and chaperonopathies. While AD is a widely recognized medical, public health, and social problem, the chaperonopathies have not yet been acknowledged as a related burden

Chaperonoterapy for Alzheimer's Diseases: Focusing on HSP60

2015

Abstract

This review will analyze growing evidence suggesting a convergence between two major areas of research: Alzheimer's disease (AD) and chaperonopathies. While AD is a widely recognized medical, public health, and social problem, the chaperonopathies have not yet been acknowledged as a related burden
2015
Inglese
Alexzander A.A. Asea
Heat Shock Protein-Based therapies
51
76
978-3-319-17210-1
Springer International Publishing
CH-6330 Cham (ZG)
SVIZZERA
Sì, ma tipo non specificato
chaperonin
hsp60
neurodegenerative diseases
2
02 Contributo in Volume::02.01 Contributo in volume (Capitolo o Saggio)
268
none
Cappello; FrancescoGammazza; Antonella MarinoVilasi; SilviaOrtore; Maria GraziaSan Biagio; Pier LuigiCampanella; ClaudiaPace; AndreaPiccionello Palum...espandi
info:eu-repo/semantics/bookPart
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/301845
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact